Trial Profile
A phase I study of BMS-275183 given on a daily schedule in patients with advanced malignancies
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 31 May 2007
Price :
$35
*
At a glance
- Drugs BMS 275183 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 13 Nov 2005 New trial record.